San Diego-based life sciences equipment maker Illumina said Thursday that it has received a favorable outcome in its patent litigation against Life Technologies. Illumina said that a judge in the U.S. District Court for the Southern District of California granted it summary judgement, saying that its sequencing systems do not infringe U.S. Patent Nos. 5,616,478; 5,958,698 and 6,001,568, which are owned by Life Technologies. Life Technologies sued Illumina over the patents in 2009. The ruling comes only days fater Illumina was ordered to pay $96M in another patent lawsuit involving Syntrix Biosystems. The life sciences and sequencing market seems to be a hotbed of patent lawsuits; Illumina is also engaged in another patent lawsuit fight with Complete Genomics, and also had sued Affymetrix in 2009.
Top NewsThursday, March 21, 2013
Illumina Wins Favorable Ruling In Patent Suit